shop now
clinical laboratory standards institute logo

 

About CLSI

 

Share Your Comments on New and Revised Standard Documents

Help shape the standards that impact your day-to-day work.

To preserve the integrity of standards developed through the CLSI consensus process, we seek input from the public on our in-process drafts before they are approved for publication. Opening the dialogue to CLSI members and non-members alike, we encourage your involvement in the final shaping of our documents to ensure that all interested parties are given a voice.

General Information

Comments related to CLSI draft documents shall be made in writing using the comment table form and shall be submitted no later than the comment deadline indicated above. Comments, as well as requests for a copy of the document, should be submitted via e-mail to standard@clsi.org or by fax to 610.688.0700.

Documents for Review and Comment

C52 (Proposed Draft)—Toxicology and Drug Testing in the Medical Laboratory

Voting Deadline: 5 May 2016

This guideline overviews drug testing for both drugs of abuse and other drugs normally analyzed by medical laboratories. The guideline discusses the preexamination, examination, and postexamination considerations for specimen collection, methods of analysis, and the reporting and interpretation of results.

This draft document is available to the public for review and comment for 60 days (March 4 to May 5).

C49 (Proposed Draft)—Analysis of Body Fluids in Clinical Chemistry

Voting Deadline: 23 May 2016

This guideline provides information for the medical laboratory for evaluating measurement procedures, as well as a strategy to characterize assay performance when applied to body fluid matrixes. Key concepts that apply to the entire test cycle, including preexamination, examination, and postexamination phases of body fluid testing are discussed.

This draft document is available to the public for review and comment for 60 days (March 25 to May 23).

M58 (Proposed Draft)—Methods for the Identification of Cultured Microorganisms Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.

Voting Deadline: 7 June 2016

This guideline includes performance, reporting, and quality assurance recommendations for the identification of cultured microorganisms by medical laboratory professionals using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Recommendations for end-user verification and workflow integration are also included.

This draft document is available to the public for review and comment for 60 days (April 7 to June 7)


The review and comment period helps ensure that consensus is achieved so that approved consensus documents can be distributed for use in the health care community. At the end of the 60-day review and comment period, the committee that developed the document is obligated to review all comments, respond in writing to all substantive comments, and revise the draft document as appropriate. CLSI greatly appreciates your valuable feedback.

Please note draft CLSI documents are available only for the purposes of review and comment, and are not to be reproduced or circulated for any other reason. Draft documents have not completed the consensus review process, and therefore, shall not be used for any clinical purposes or to satisfy regulatory or accreditation requirements. They should not to be considered either final or published and may not be quoted or referenced.

 

Did You Know?

CLSI distributes more than
75,000 standards and guidelines per year, worldwide.

Login


3 × nine =


Register | Lost your password?